Winner of the VSP Vision Innovation Challenge. Featured on the Future of Oculomics & the Futurist Report by

VSP Vision Logo
Telehealth PortalImage Hub

Better Data.
Better Decisions.
Better Eye Health.

sales@vitazi.ai

1 (833) 4-VITAZI

11622 El Camino Real Suite 100 San Diego, CA 92130
1620 Broadway Suite F2 Scottsbluff, NE 69361
3900 Paseo del Sol Santa Fe, NM 87507
HIPAA Compliant

Share your Thoughts

Book Demo
Vitazi.ai Inc. All Rights Reserved.
Privacy Policy|Terms of Service

The statements made regarding products or services have not been evaluated by the Food and Drug Administration. The efficacy of these products or services has not been confirmed by FDA-approved research. These products and/or services are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product or service. The U.S. Food and Drug Administration requires this notice. Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence.

Jan 21, 2025
Oculomics

The Challenges of Using a Handheld Retinopathy Scanner vs. the Benefits of Vitazi-MD

Retinopathy screening has become a critical component in the early detection and management of diabetic retinopathy and other diseases that impact the retina.

jeremy

Jeremy Stueven

CEO

Jan 7, 2025
Oculomics

Diabetic Retinopathy: Stages, Treatments, and Prevention Strategies

Diabetic retinopathy is a leading cause of vision loss worldwide, affecting individuals with diabetes who experience damage to the blood vessels in their retina.

jeremy

Jeremy Stueven

CEO

Dec 10, 2024
Oculomics

Integrating AI into Teleretinal Platforms: Challenges and Opportunities — Vitazi.ai

The intersection of artificial intelligence (AI) and telemedicine has ushered in a new era of healthcare delivery, particularly in the field of ophthalmology. Teleretinal platforms, which enable remote diagnosis and monitoring of eye diseases, have gained significant traction in recent years.

jeremy

Jeremy Stueven

CEO

Dec 4, 2024
Oculomics

The Future of AI in Ophthalmology: From Screening to Personalized Treatment

The field of ophthalmology is on the brink of a revolution driven by the rapid advancements in artificial intelligence (AI).

jeremy

Jeremy Stueven

CEO

Nov 19, 2024
Oculomics

AI and Oculomics: A New Frontier in Disease Detection

Oculomics, the study of the association between ophthalmic biomarkers (changes or abnormalities in the eye) and systemic health or disease states, has emerged as a fascinating field with significant potential for medical diagnosis

jeremy

Jeremy Stueven

CEO

Nov 7, 2024
Oculomics

AI-Powered Retinal Imaging: Enhancing Diagnostic Accuracy in Ophthalmology

The field of ophthalmology has witnessed significant advancements in recent years, thanks to the integration of artificial intelligence (AI) into various diagnostic procedures. One such breakthrough is the utilization of AI-powered retinal imaging

jeremy

Jeremy Stueven

CEO

Oct 29, 2024
Oculomics

The Role of AI in Addressing Diabetic Retinopathy: Early Detection and Better Outcomes

Diabetic retinopathy (DR) is a leading cause of blindness, particularly among diabetic patients.

jeremy

Jeremy Stueven

CEO

Oct 21, 2024
Oculomics

How AI is Revolutionizing Teleretinal Screening for Early Detection of Eye Diseases

The Power of AI in Eye Care. In healthcare, artificial intelligence (AI) is making significant strides, particularly in the field of ophthalmology.

jeremy

Jeremy Stueven

CEO